Towards a TDP-43-based biomarker for ALS and FTLD
TDP-43 accumulates in nerve cells of nearly all cases of amyotrophic lateral sclerosis (ALS, the commonest form of motor neuron disease) and in the majority of Tau-negative frontotemporal lobar degeneration (FTLD). There is currently no biochemical test or marker of disease activity for ALS or FTLD...
Main Authors: | Feneberg, E, Gray, E, Ansorge, O, Talbot, K, Turner, M |
---|---|
Format: | Journal article |
Published: |
Springer US
2018
|
Similar Items
-
Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP
by: Feneberg, E, et al.
Published: (2021) -
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
by: Sarah Pickles, et al.
Published: (2022-07-01) -
The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01) -
FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.
by: Bäumer, D, et al.
Published: (2014) -
TDP-43 based biomarker development in amyotrophic lateral sclerosis
by: Feneberg, E
Published: (2019)